Cas:104144-06-1 N,N-Di(3-buten-1-yl)-4-methylbenzenesulfonamide manufacturer & supplier

We serve Chemical Name:N,N-Di(3-buten-1-yl)-4-methylbenzenesulfonamide CAS:104144-06-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N,N-Di(3-buten-1-yl)-4-methylbenzenesulfonamide

Chemical Name:N,N-Di(3-buten-1-yl)-4-methylbenzenesulfonamide
CAS.NO:104144-06-1
Synonyms:FD7111;N,N-di-3-butenyl-p-toluenesulfonamide;BEN197;N,N-di-but-3-enyl-4-methyl-benzenesulfonamide;Benzenesulfonamide, N,N-di-3-buten-1-yl-4-methyl-;N,N-Di(3-buten-1-yl)-4-methylbenzenesulfonamide;Benzenesulfonamide,N,N-di-3-butenyl-4-methyl;Benzenesulfonamide,N,N-di-3-buten-1-yl-4-methyl
Molecular Formula:C15H21NO2S
Molecular Weight:279.398
HS Code:2935009090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:387.3±52.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.532
PSA:45.76000
Exact Mass:279.129303
LogP:4.47

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like FD7111 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenesulfonamide,N,N-di-3-buten-1-yl-4-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N-di-3-butenyl-p-toluenesulfonamide Use and application,N,N-Di(3-buten-1-yl)-4-methylbenzenesulfonamide technical grade,usp/ep/jp grade.


Related News: Researchers engineered IgM antibodies and found that in all cases, these antibodies were significantly more potent than standard IgG antibodies in neutralizing the COVID-19 virus. N4-[3-(benzyloxy)phenyl]-2-[4-(3-chlorophenyl)-1-piperazinyl]-N6,N6-dimethyl-4,6-pyrimidinediamine manufacturers Atom utilization is also better with biocatalysis; where two or more moieties on the same molecule have the capacity to undergo a particular reaction, biocatalytic processing guarantees that one site is consistently chosen over the other. 9-[N-(2-hydroxyethyl)-N-methyl]aminomethyl anthracene suppliers The review by EMA’s safety committee (PRAC) supported by experts from the Committee for Advanced Therapies (CAT) found that the viral vector was unlikely to be the cause. W2(μ-CSiMe3)2(CH2SiMe3)4[η2-C2(H)(Me)] vendor & factory.